Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.1M
Filings
20
Firms Hired
2
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Mikaela Naylon Give Kids a Chance Act
2026 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1262
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1672
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.946
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.1862
Give Kids a Chance Act of 2025
2026 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.932
Justice for Victims of Fraud Act of 2017
2026 · third_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1414
Mikaela Naylon Give Kids a Chance Act
2026 · third_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1262
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1672
Maintaining Investments in New Innovation Act
2026 · third_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1672
Give Kids a Chance Act of 2025
2026 · third_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: S.932
Justice for Victims of Fraud Act of 2017
2026 · second_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1414
Mikaela Naylon Give Kids a Chance Act
2026 · second_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1262
Maintaining Investments in New Innovation Act
2026 · second_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1672
Maintaining Investments in New Innovation Act
2026 · second_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: H.R.1672
Give Kids a Chance Act of 2025
2026 · second_quarter · Firm: IONIS PHARMACEUTICALS, INC.
Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. Issues related to drug pricing policy.
Client expense: $150,000 · Firm income: —
Matched citations: S.932
Mikaela Naylon Give Kids a Chance Act
2026 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1262
Maintaining Investments in New Innovation Act
2026 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1672
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.946
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.1862
Give Kids a Chance Act of 2025
2026 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.932
Mikaela Naylon Give Kids a Chance Act
2026 · first_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1262
Maintaining Investments in New Innovation Act
2026 · first_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1672
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.946
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.1862
Give Kids a Chance Act of 2025
2026 · first_quarter · Firm: LMH STRATEGIC SOLUTIONS
Pediatric Review Reauthorization. H.R.946/S.1862: ORPHAN Cures Act. H.R.1672: Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932: Give Kids a Chance Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: S.932
Source: Senate LDA